BAYOOMED @Digital Biomarkers in Clinical Trials Summit 2026

Our CEO Miriam Schulze will attend PanAgora Pharma’s Digital Biomarkers in Clinical Trials Summit 2026. The event will take place on June 23, 2026 at the Roche site in Basel and will bring together international experts from clinical research, digital health and pharma.

The summit will focus on current developments relating to digital biomarkers, patient-centered clinical trials and the use of digital health technologies (DHTs) in modern study concepts. In addition, topics such as AI-supported innovations, data use, regulatory requirements and virtual or decentralized study approaches will be discussed.

Leading representatives from pharma, research and technology will provide insights into new strategies to improve study quality, patient engagement and data-driven decision making in clinical trials.

With her many years of experience in the fields of digital health technologies, regulatory affairs and quality management, Miriam Schulze is looking forward to the professional exchange with international experts and innovators in the industry.

The summit offers a valuable platform for new impulses, practical discussions and exchange on the future of digital biomarkers and innovative clinical trials.